Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
BMC Health Services Research|December 12, 2025
Do discharge delays explain longer stays at veterans health administration hospitals?Brian P Lucas, Daniel M Weinberger, Anita A Vashi, et al.Vaccine|June 30, 2022
Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysisCaroline Korves, Hector S Izurieta, Jeremy Smith, et al.Pain Medicine (Malden, Mass.)|October 12, 2013
Systematic literature review and meta-analysis of the efficacy and safety of prescription opioids, including abuse-deterrent formulations, in non-cancer pain managementEdward Michna, Wendy Y Cheng, Caroline Korves, et al.Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Absolute and relative excess mortality across demographic and clinical subgroups during the COVID-19 pandemic: an individual-level cohort study from a nationwide healthcare system of US VeteransDaniel M Weinberger, Krishnan Bhaskaran, Caroline Korves, et al.Clinical Ophthalmology (Auckland, N.Z.)|March 17, 2021
Real-World Experience with Lifitegrast Ophthalmic Solution (Xiidra®) in the US and Canada: Retrospective Study of Patient Characteristics, Treatment Patterns, and Clinical Effectiveness in 600 Patients with Dry Eye DiseaseJohn A Hovanesian, Kelly K Nichols, Mitchell Jackson, et al.Prostate Cancer and Prostatic Diseases|August 21, 2020
Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology centerRana R McKay, Rebecca Silver, Rachel H Bhak, et al.International Journal of Epidemiology|October 6, 2023
Excess mortality in US Veterans during the COVID-19 pandemic: an individual-level cohort studyDaniel M Weinberger, Krishnan Bhaskaran, Caroline Korves, et al.BMC Cancer|April 18, 2015
A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatmentsMichael J Wagner, Leo Ismaila Amodu, Mei Sheng Duh, et al.Mbio|August 3, 2023
Tixagevimab/cilgavimab for preventing COVID-19 during the Omicron surge: retrospective analysis of National Veterans Health Administration electronic dataYinong Young-Xu, Lauren Epstein, Vincent C Marconi, et al.Open Forum Infectious Diseases|December 28, 2023
Effectiveness of Sotrovimab in Preventing COVID-19-Related Hospitalizations or Deaths Among US Veterans During Omicron BA.1Yinong Young-Xu, Caroline Korves, Gabrielle Zwain, et al.Pageof 3